Company Filing History:
8 out of 343 
3 out of 6 
1 out of 1 Years Active: 1994-2025
Title: Innovations by Mara Ferrandi in Heart Failure Treatment
Introduction
Mara Ferrandi is a prominent inventor based in Milan, Italy, known for her significant contributions to the field of pharmaceuticals, particularly in the treatment of heart failure. With a total of 12 patents to her name, she has made remarkable strides in developing innovative therapies that address critical health issues.
Latest Patents
Among her latest patents is the "Istaroxime-containing intravenous formulation for the treatment of acute heart failure (AHF)." This patent discloses compositions for intravenous infusion of istaroxime, or its metabolites, in patients suffering from heart failure. The methods outlined include extended infusion of istaroxime for over six hours to enhance cardiac relaxation without causing arrhythmogenic events. Additionally, her work includes the administration of istaroxime until specific plasma concentration thresholds of its metabolites are reached. Another notable patent is for "17beta-heterocyclyl-digitalis like compounds for the treatment of heart failure." This patent describes compounds that can be used as medicaments for both acute and chronic heart failure, with the possibility of oral administration.
Career Highlights
Mara Ferrandi has worked with notable companies in the pharmaceutical industry, including Sigma-Tau Industrie Farmaceutiche Riunite S.p.a. and Windtree Therapeutics, Inc. Her career reflects a commitment to advancing medical science and improving patient outcomes through innovative drug development.
Collaborations
Throughout her career, Ferrandi has collaborated with esteemed colleagues such as Patrizia Ferrari and Giuseppe Bianchi. These partnerships have contributed to her success and the advancement of her research in the field of heart failure treatment.
Conclusion
Mara Ferrandi's work exemplifies the impact of innovation in medicine, particularly in addressing heart failure. Her patents and collaborations highlight her dedication to improving healthcare through scientific advancements.